These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 316447)

  • 1. Lymphocyte subpopulations in multiple sclerosis: serial studies and clinical correlations.
    Sagar HJ; Allonby ID
    J Neurol Sci; 1979 Sep; 43(1):133-48. PubMed ID: 316447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-typing and lymphocyte population studies in patients with multiple sclerosis.
    Reekers P; Hommes OR; Creemers-Molenaar J; Wijnings J; Kunst VA; Van Rood JJ
    J Neurol Sci; 1977 Aug; 33(1-2):143-53. PubMed ID: 71339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse?
    Thompson AJ; Brazil J; Whelan CA; Martin EA; Hutchinson M; Feighery C
    J Neurol Neurosurg Psychiatry; 1986 Aug; 49(8):905-12. PubMed ID: 2943874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subpopulations in the blood and cerebrospinal fluid of multiple sclerosis patients in active disease.
    Rukavina D; Sepcić J; Dorić M; Ledić P; Zaputović L; Eberhardt P
    Acta Neurol Scand; 1984 Mar; 69(3):182-5. PubMed ID: 6609518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subpopulations in the cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Członkowska A; Półtorak M; Cendrowski W; Korlak J
    Acta Neurol Scand; 1980 Jul; 62(1):55-62. PubMed ID: 6971037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte subpopulations in multiple sclerosis (MS). A contribution].
    Nuccetelli F; Assetta M; Tartaro A; Di Muzio A; Nanni Costa E; Anichini M; Gambi D
    Minerva Med; 1989 Mar; 80(3):189-93. PubMed ID: 2654756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
    Kastrukoff LF; Paty DW
    Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity in acute idiopathic optic neuritis and multiple sclerosis.
    Sagar HJ; Allonby ID
    Acta Neurol Scand; 1981 Jun; 63(6):362-72. PubMed ID: 6976672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood B and T-lymphocyte populations in patients with multiple sclerosis. Relationship with clinical activity of the disease and chronic immunosuppressive treatment.
    Chalon MP; Sindic CJ; Boon L; Laterre EC
    Acta Neurol Belg; 1987; 87(5):245-60. PubMed ID: 3501665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphocyte subpopulations in peripheral blood of patients with multiple sclerosis, patients with other neurological diseases and healthy controls.
    de Graaf J; Minderhoud JM; Teelken AW
    Clin Neurol Neurosurg; 1986; 88(3):181-7. PubMed ID: 3022975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood lymphocyte subpopulations show characteristic changes during ACTH therapy in acute exacerbations of multiple sclerosis.
    Kaschka WP; Hilgers R
    Acta Neurol Scand; 1980 May; 61(5):275-86. PubMed ID: 6247876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls.
    Kreuzfelder E; Shen G; Bittorf M; Scheiermann N; Thraenhart O; Seidel D; Grosse-Wilde H
    Eur Neurol; 1992; 32(4):190-4. PubMed ID: 1505587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis.
    Prieto A; Díaz D; Barcenilla H; Castrillo C; Monserrat J; Merino AG; Alvarez-Mon M;
    J Clin Immunol; 2006 Mar; 26(2):101-12. PubMed ID: 16758338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
    Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients.
    Scolozzi R; Boccafogli A; Tola MR; Vicentini L; Camerani A; Degani D; Granieri E; Caniatti L; Paolino E
    J Neurol Sci; 1992 Mar; 108(1):93-8. PubMed ID: 1352538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of the T cell activation marker CD26 in chronic progressive multiple sclerosis.
    Constantinescu CS; Kamoun M; Dotti M; Farber RE; Galetta SL; Rostami A
    J Neurol Sci; 1995 Jun; 130(2):178-82. PubMed ID: 8586983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
    Mar P; Gradl T; Dörner C; Contag I
    Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis.
    Allen JC; Sheremata W; Cosgrove JB; Osterland K; Shea M
    Neurology; 1976 Jun; 26(6 PT 1):579-83. PubMed ID: 1084494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens and mitogen responsiveness in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):187-9. PubMed ID: 300927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.